Sarepta Therapeutics Inc (SRPT)
Fixed asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 1,901,979 | 1,640,348 | 1,504,993 | 1,403,300 | 1,243,336 | 1,104,982 | 1,003,434 | 975,683 | 933,013 | 876,047 | 835,184 | 765,786 | 701,887 | 645,564 | 600,082 | 573,356 | 540,099 | 495,074 | 450,191 | 407,496 |
Property, plant and equipment | US$ in thousands | — | — | — | — | — | — | — | 347,006 | 244,991 | 181,005 | 183,292 | 187,248 | 191,156 | 199,249 | 276,198 | 203,107 | 190,430 | 171,715 | 153,340 | 137,325 |
Fixed asset turnover | — | — | — | — | — | — | — | 2.81 | 3.81 | 4.84 | 4.56 | 4.09 | 3.67 | 3.24 | 2.17 | 2.82 | 2.84 | 2.88 | 2.94 | 2.97 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $1,901,979K ÷ $—K
= —
The fixed asset turnover ratio for Sarepta Therapeutics Inc has shown some fluctuations over the past few years. From March 31, 2020, to June 30, 2021, the ratio declined steadily from 2.97 to 2.17, indicating a decrease in the company's ability to generate revenue from its fixed assets. However, from September 30, 2021, to June 30, 2022, there was a significant improvement in the ratio, reaching a peak of 4.56 on June 30, 2022. This suggests that the company was able to generate more revenue relative to its investment in fixed assets during this period.
Although the ratio declined slightly to 3.81 by December 31, 2022, it still remained at a higher level compared to the previous years. Subsequently, the fixed asset turnover ratio decreased further to 2.81 by March 31, 2023, indicating a possible decline in revenue generated from fixed assets. It is worth noting that the data for the remainder of 2023 and all of 2024 is not available in the provided dataset.
Overall, Sarepta Therapeutics Inc's fixed asset turnover ratio has shown some variability, with periods of both improvement and decline. This ratio is important as it reflects the efficiency of the company in utilizing its fixed assets to generate revenue. Further analysis and additional data would be needed to assess the long-term trend and implications of these fluctuations on the company's operational performance.
Peer comparison
Dec 31, 2024